Cronos Group Stock Analysis

Cronos Stock Analysis Notes

About 46.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.74. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cronos Group recorded a loss per share of 0.12. The entity had not issued any dividends in recent years. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada. Cronos operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 626 people. For more info on Cronos Group please contact Michael JD at 416 504 0004 or go to https://www.thecronosgroup.com.

Cronos Group Investment Alerts

Cronos Group Upcoming and Recent Events

Cronos Largest EPS Surprises

View All Earnings Estimates

Cronos Environmental, Social, and Governance (ESG) Scores

Cronos Thematic Classifications

Cronos Stock Institutional Investors

Note, although Cronos' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Cronos Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 795.17 M.

Cronos Profitablity

The company has Profit Margin (PM) of (0.56) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.54) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.54.

Management Efficiency

Cronos Group has return on total asset (ROA) of (0.0373) % which means that it has lost $0.0373 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0529) %, meaning that it created substantial loss on money invested by shareholders. Cronos' management efficiency ratios could be used to measure how well Cronos manages its routine affairs as well as how well it operates its assets and liabilities. As of the 26th of November 2024, Return On Tangible Assets is likely to grow to -0.06. In addition to that, Return On Capital Employed is likely to drop to -0.08. At this time, Cronos' Non Current Assets Total are very stable compared to the past year. As of the 26th of November 2024, Other Current Assets is likely to grow to about 6.5 M, while Total Assets are likely to drop about 808.6 M.

Technical Drivers

As of the 26th of November, Cronos shows the Standard Deviation of 3.13, mean deviation of 2.15, and Risk Adjusted Performance of (0.02). Cronos Group technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Cronos Group Price Movement Analysis

Cronos Group Insider Trading Activities

Cronos Outstanding Bonds

Cronos Predictive Daily Indicators

Cronos Corporate Filings

Cronos Forecast Models

Cronos' time-series forecasting models are one of many Cronos' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cronos' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Cronos prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cronos shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Cronos. By using and applying Cronos Stock analysis, traders can create a robust methodology for identifying Cronos entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Cronos analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Cronos analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Cronos Group stock analysis indicators help investors evaluate how Cronos stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Cronos shares will generate the highest return on investment. By understating and applying Cronos stock analysis, traders can identify Cronos position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cronos Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cronos. If investors know Cronos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cronos listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Cronos Group is measured differently than its book value, which is the value of Cronos that is recorded on the company's balance sheet. Investors also form their own opinion of Cronos' value that differs from its market value or its book value, called intrinsic value, which is Cronos' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cronos' market value can be influenced by many factors that don't directly affect Cronos' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cronos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cronos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cronos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.